COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02657161
Recruitment Status : Completed
First Posted : January 15, 2016
Last Update Posted : January 15, 2016
Duke-NUS Graduate Medical School
Information provided by (Responsible Party):
Yisheng Biopharma (Singapore) Pte. Ltd.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2015
Actual Study Completion Date : July 2015